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Background: Pharmacist implemented transitions-of-care (TOC) programs focus on identifying 
adherence issues, developing care plans, investigating medication-related insurance problems, 
and instilling the value of medication treatment in patients frequently admitted to hospitals for 
manageable, chronic disease-states.  
Study objective: The primary objective of this study is to determine the impact of pharmacist 
interventions during a TOC pilot on hospital readmission rates for patients with acute myocardial 
infarction (AMI), heart failure (HF), chronic obstructive pulmonary disease (COPD), or 
pneumonia.  
Methods: This study is a retrospective review of patients receiving high intensity care to prevent 
readmission, including pharmacy intervention during a three-month pilot period versus patients 
with the same disease states not receiving high intensity care. The patient population includes 
patients greater than 18 years of age who were admitted for AMI, HF, COPD, or pneumonia. 
Patients were excluded if less than 18 years of age and prisoners.  
Results: Hospital records identified 513 patients eligible for study inclusion following removal 
of exclusion patients. The study showed no statistical evidence to conclude that pharmacy 
intervention has effect on readmission rate when pharmacy intervention in the Medicare 
population was compared to the non-pharmacy intervention Medicare population (Fisher’s Exact 
P = 0.123). 
Conclusion: The study failed to show a significant difference in readmissions for patients 
receiving additional pharmacy care. Other factors play a role in readmission risk. Additional 
studies including more patients and comparing risk factors for readmission are needed to 
determine best practices to reduce risk while promoting patient health. 
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Background 
There is a trend of underutilization of pharmacists to provide intervention on medication 
adherence for patients. Lack of adherence puts patients at increased risk for readmission, decline 
in health, and morbidity and mortality. This also creates a greater burden on the health system as 
hospitals are not reimbursed by government payors for readmissions within 30 days for certain 
disease states. In an effort to prevent further readmissions, provide better quality of life, and 
prevent reimbursement penalties, pharmacists are implementing transitions-of-care (TOC) 
programs. These programs focus on identifying adherence issues, developing care plans, 
investigating medication-related insurance problems, and instilling the value of medication 
treatment in patients frequently admitted to hospitals for manageable, chronic disease-states.  
 
In a study on the “Impact of a transition-of-care pharmacist during hospital discharge”, 
pharmacists were involved in the education of 1,011 patients, performing 452 interventions  
which lead to a decline in the overall readmissions per month (P = 0.0369).1 Interventions 
included starting an omitted medication from previous admission, preventing discharge 
problems, avoiding medication duplication, correcting medication-coverage insurance issues, 
revising improper medication dose or quantity, changing inappropriate medications, and 
resolving other problems pursuant to the patient’s medication. The findings indicated that a 
transition-of-care pharmacist is in a unique position to educate patients, and resolve medication 
errors and insurance problems which may result in reduced hospital readmission rates. 
 
At New Hanover Regional Medical Center, a transitions of care protocol was implemented 
through collaboration with a general medicine pharmacist, nurse and case manager.2 The 
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discharge pilot focused on transitioning patients from inpatient to outpatient status with the 
inpatient, general medicine pharmacist coordinating education and information with the 
outpatient pharmacist. The baseline readmission rate for high-risk patients, those with high 
readmission rates, chronic disease states, large number of medications, and psychosocial 
concerns, to the general medicine floor was 17.88%. Following the pilot intervention, 
readmission rates for these patients decreased to 15.31%. Those patients, with the general 
medicine pharmacist-provided medication reconciliation and education, had a readmission of 
14.67%. Furthermore, patients who elected to have their medications filled in the outpatient 
pharmacy had a readmission rate of 9%. This study showed that pharmacist intervention may 
have an impact on readmission rates by helping to streamline processes for better medication 
adherence in high-risk patients.  
 
With the implementation of the Affordable Care Act (ACA), further focus has been placed on 
coordination of care and reducing unnecessary medical expenditure.4 In response to the act, the 
Centers for Medicare and Medicaid Services (CMS) enacted cost-saving strategies to reduced 
readmissions. CMS will not fully reimburse hospitals if patients with disease states such as acute 
myocardial infarction (AMI), chronic heart failure, chronic obstructive pulmonary disease 
(COPD), or pneumonia are readmitted within 30 days of discharge. 
 
Eskenazi Health is dedicated to serving the unprivileged and thus serves a large portion of 
Medicaid and Medicare patients in central Indiana.3 Financial stability is marked by the 
cornerstone of receiving payment and reimbursement for medical services through CMS. Due to 
the necessity and the concern for patients frequently readmitted, inpatient pharmacists have 
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implemented a transitions-of-care (TOC) pilot which focuses on patients with a primary or 
secondary diagnosis of AMI, HF, COPD, or pneumonia. The pharmacists implemented processes 
to provide discharge medication reconciliation and discharge counseling, evaluation medication 
adherence, accessibility, cost, insurance issues, and secure accessibility to medications upon 
discharge to prevent hospital readmission. 
 
Study Significance  
The study attempts to show the impact of pharmacist intervention in transitioning patients from 
hospital to home, and the potential impact of these interventions on reducing readmission rates in 
patients who are at high risk for readmission. 
 
Study Objective  
The primary objective of this study is to determine the impact of pharmacist interventions during 
the TOC pilot on hospital readmission rates for patients with AMI, HF, COPD, or pneumonia. 
Secondary objectives include characterizing the pharmacist interventions, amount of time 
dedicated to the pilot interventions, and patient adherence based on medication fill history. 
 
Methods 
Study Design  
The study is a retrospective review of patients receiving high intensity care including pharmacy 
intervention during a three month pilot period versus patients with the same disease states not 
receiving high intensity care. 
 
 6 
 
Study Data Source 
The data source is through records obtained through electronic medical records at Eskenazi 
Health.  
Inclusion Criteria  
The inclusion criteria for the study is patients greater than 18 years of age who have previous 
admission for AMI, HF, COPD, or pneumonia  
Exclusion Criteria  
The exclusion criteria for the study is patients less than 18 years of age, prisoners, and patients 
who did not have a diagnosis of AMI, HF, COPD, or pneumonia  
Measurement of Variables 
Measurement of variables include an analysis of readmission within 30-days post-discharge, 
number of pharmacist interventions, time spent on interventions, pharmacy fill history post-
discharge, number of medications post-discharge, and number of co-morbid conditions.  
Control Variables 
Control variables include readmission within 30-days post-discharge, pharmacy fill history post-
discharge, number of medications post-discard, number of co-morbid conditions, and length of 
stay while in hospital.  
Statistical Analysis 
Statistical analysis of the data is through a CHI square test, Fisher’s exact test, and Student T 
test.   
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Results & Discussion  
Hospital records identified 513 patients eligible for study inclusion following removal of 
exclusion patients. Baseline demographics (gender, age, race) are similar between the 
intervention potential group overall (Medicare population) versus non-intervention group (other 
insurance/no insurance population). COPD followed by mixed presentation, in which it was 
undetermined which target disease state was the cause of readmission, are the highest causes for 
admission in both groups. COPD is the highest cause of readmission in the pharmacy, Medicare 
intervention group. Heart failure is the highest for readmission in the non-intervention, other 
insurance/no insurance group. There were 13 patients readmitted within 30 days following 
pharmacy intervention in the Medicare group (8 readmitted from the target disease in question), 
compared to 62 in the non-pharmacy intervention Medicare group (25 from target disease) and 
30 in the non-intervention, other insurance/no insurance group (5 from target disease).  Table 1 
summarizes the data below.  
 
The results show that, per the CHI square test comparing all three test groups, differences seen 
are not due to randomness (P < 0), but that there are no statistical differences between the 
Medicare populations versus other insurance/no insurance study population (T test P = 0.617). 
There is also no statistical evidence to conclude that pharmacy intervention has effect on 
readmission rate when pharmacy intervention in the Medicare population was compared to the 
non-pharmacy intervention Medicare population (Fisher’s Exact P = 0.123). It should be noted 
that the pharmacy, Medicare-population intervention group consisted of only 46 patients of 237 
possible. This can affect the variance of the statistical analysis and subjects it to high level of 
factors not attributable solely to pharmacy intervention.  
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Conclusion  
Although pharmacist intervention is meant to reduce the risk of readmission through proper 
counseling and management of medications, this study failed to show a significant difference in 
readmissions for patients receiving additional pharmacy care. Other factors play a role in 
readmission risk such as lack of adherence following education, health literacy issues, and 
unavoidable readmissions (i.e. bone fractures). Additional studies including more patients and 
comparing risk factors for readmission are needed to determine best practices to reduce risk 
while promoting patient health. 
 
Study Limitations 
This study is limited to Eskenazi Health in Indianapolis, Indiana and includes patients with four 
specific disease states—AMI, HF, COPD, or pneumonia. The study population does not include 
any patient under the age of 18 years old, nor any prisoners who might otherwise fall into 
inclusion criteria. These factors make this study less widely applicable to the general population.  
 
The study only includes data from three month time period and is limited by number of 
pharmacists able to participate in active interventions. The pilot study was conducted on patients 
with Medicare Part D versus the control group that includes patients with other payers as well as 
patients without insurance, and thus may contribute to other factors for readmission in the 
control group not assessed by the study. 
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Table 1. Descriptive statistics between groups 
 Intervention 
Group – 
Medicare Patient 
  Non-intervention 
– Other 
Insurance/None 
  Medicare 
Patient – 
Pharmacy 
Intervention 
Medicare Patient 
– No Pharmacy 
Intervention  
 
Patient (n) 237 46 191 276 
Males 94 19 75 145 
Females 143 27 116 131 
Mean age 66.160 67.043 65.948 57.029 
Caucasian 112 25 87 128 
African American 123 20 103 127 
Other  2 1 1 21 
Admission 
diagnosis: Heart 
Failure  
67 7 60 82 
Admission 
diagnosis: 
Myocardial 
Infarction 
4 1 3 11 
Admission 
diagnosis: COPD 
77 18 59 85 
Admission 
diagnosis: 
Pneumonia 
14 3 11 30 
Admission 
diagnosis: Mixed 
presentation  
75 17 58 68 
Mean length of 
stay (days)  
4.168 3.870 4.241 4.674 
Median length of 
stay (days) 
3 3 3 3 
Range 45-1 8-1 45-1 33-1 
Mean number of 
comorbid 
conditions  
7.468 7.304 7.508 5.920 
Median number 
of comorbid 
conditions  
7 7 7 5 
Range 22-0 15-2 22-0 21-0 
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Mean number of 
medications at 
admission  
11.008 10.609 11.105 7.855 
Median number 
of medications at 
admission  
11 11 11 8 
Range 24-0 18-0 24-0 26-0 
Mean number of 
medications at 
discharge 
15.139 15.130 15.141 12.293 
Median number 
of medications at 
discharge  
15 15 15 11.5 
Number of 
pharmacy 
interventions 
- 46 - - 
Mean time (min) 
of pharmacy 
intervention 
- 33.913 - - 
Median time 
(min) of 
pharmacy 
intervention 
- 30 - - 
Mean number of 
interventions 
made 
- 4.522 - - 
Median number 
of interventions 
made  
- 3 - - 
Mean number of 
interventions 
accepted 
- 4.391 - - 
Median number 
of interventions 
accepted  
- 3 - - 
Claimed patient 
pharmacy: 
Eskenazi 
93 20 73 136 
Claimed patient 
pharmacy: Other 
144 26 118 140 
Number of 
patients utilizing 
Eskenazi 
outpatient 
pharmacy 
82 20 62 91 
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Number of 
patients utilizing 
“Other” 
pharmacies 
155 26 129 35 
Number of 
patients with 
confirmed fills  
89 22 67 124 
Mean number of 
medications filled 
at discharge  
4.561 4.774 4.313 5.073 
Median number 
of medications 
filled at discharge 
4 4 4 5 
Range 18-0 18-0 16-0 17-1 
Number 
readmitted within 
30 days 
75 13 62 30 
Number 
readmitted with 
target disease 
state  
33 8 25 5 
Readmission 
diagnosis: HF 
12 1 11 3 
Readmission 
diagnosis: MI 
2 - 2 - 
Readmission 
diagnosis: COPD 
15 6 9 1 
Readmission 
diagnosis: 
Pneumonia 
3 - 3 1 
Readmission 
diagnosis: Mixed 
presentation 
1 1 - - 
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